GFAP and neoplasm: This might reflect that tonabersat is active at the infiltrative border of the tumor, which can be confirmed by histological analysis that showed enhanced Cx43 expression and GFAP-positive reactive astrocytes at the peritumoral zone of GB, indicative for gliomagenesis, tumor progression and treatment resistance.